AvantorAVTR
AVTR
0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 8 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
0.8% more ownership
Funds ownership: 99.62% [Q3] → 100.43% (+0.8%) [Q4]
5% less funds holding
Funds holding: 503 [Q3] → 477 (-26) [Q4]
18% less capital invested
Capital invested by funds: $17.5B [Q3] → $14.4B (-$3.09B) [Q4]
20% less repeat investments, than reductions
Existing positions increased: 165 | Existing positions reduced: 205
23% less first-time investments, than exits
New positions opened: 61 | Existing positions closed: 79
23% less funds holding in top 10
Funds holding in top 10: 13 [Q3] → 10 (-3) [Q4]
64% less call options, than puts
Call options by funds: $52.6M | Put options by funds: $145M
Research analyst outlook
8 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$18
14%
upside
Avg. target
$25
56%
upside
High target
$31
97%
upside
8 analyst ratings
6 positive
75%
2 neutral
25%
0 negative
0%
Citigroup Patrick Donnelly 23% 1-year accuracy 7 / 31 met price target | 14%upside $18 | Neutral Maintained | 4 Mar 2025 |
Morgan Stanley Tejas Savant 21% 1-year accuracy 4 / 19 met price target | 59%upside $25 | Overweight Maintained | 10 Feb 2025 |
Raymond James Andrew Cooper 13% 1-year accuracy 2 / 16 met price target | 52%upside $24 | Outperform Reiterated | 10 Feb 2025 |
RBC Capital Conor McNamara 5% 1-year accuracy 2 / 37 met price target | 97%upside $31 | Outperform Maintained | 10 Feb 2025 |
Wells Fargo Brandon Couillard 14% 1-year accuracy 3 / 21 met price target | 59%upside $25 | Overweight Maintained | 10 Feb 2025 |
Financial journalist opinion
Based on 4 articles about AVTR published over the past 30 days
Neutral
PRNewsWire
6 hours ago
Avantor® Showcases Scalable Fluid Handling Innovations at INTERPHEX
Industry leading set of technologies to drive scalability, flexibility, and efficiency in biologics production RADNOR, Pa. , April 1, 2025 /PRNewswire/ -- Avantor®, Inc., a leading global provider of mission-critical products and services for the life sciences and advanced technology industries, announces its presence at INTERPHEX, the premier annual gathering of pharmaceutical, biotechnology, and device development and manufacturing professionals.

Neutral
PRNewsWire
4 days ago
Avantor® to Report First Quarter 2025 Earnings on Friday, April 25, 2025
RADNOR, Pa. , March 28, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2025 financial results before the market opens on Friday, April 25, and will hold a conference call to discuss the results on the same day at 8:00 a.m.

Negative
Zacks Investment Research
5 days ago
Here's Why You Should Hold AVTR Stock in Your Portfolio for Now
Avantor is set for growth with a strong portfolio and solid fourth quarter results, but challenges like customer losses and forex volatility pose potential risks.

Neutral
PRNewsWire
2 weeks ago
Avantor® Provides First Look at Recently Completed Hydration Expansion at DCAT Week 2025
Facility in Gliwice, Poland to boost biopharma manufacturers' efficiency and speed to market of therapies RADNOR, Pa. , March 17, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services in the life sciences and advanced technology industries, announces that Ger Brophy, PhD, head of Avantor's Scientific Advisory Board, will present highlights of the recently completed expansion at its flagship European manufacturing site at Drug, Chemical & Associated Technologies Association (DCAT) Week 2025.

Neutral
PRNewsWire
1 month ago
Avantor® to Present at TD Cowen's 45th Annual Health Care Conference
RADNOR, Pa. , Feb. 19, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that President and CEO, Michael Stubblefield, will present at TD Cowen's 45th Annual Health Care Conference on Wednesday, March 5, at 11:50 a.m.

Neutral
Business Wire
1 month ago
Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq's Novel Surface Treatment Technology
SUNNY ISLES BEACH, Fla.--(BUSINESS WIRE)--Silq Technologies Corporation, a privately held advanced materials science company, and NuSil Technology LLC, a subsidiary of Avantor Inc., Radnor, Pa. (NYSE: AVTR), and a leading global supplier of high-quality silicones for long-term medical implants, have entered into an agreement to facilitate the utilization of Silq's zwitterionic surface treatment technology on medical devices manufactured with NuSil silicone products. Zwitterion surface technolog.

Positive
Zacks Investment Research
1 month ago
Avantor Stock Declines Despite Q4 Earnings Beat, Margins Expand
Despite AVTR's stability in proprietary chemicals and specialty procurement sales, it reports an overall soft fourth-quarter performance.

Neutral
Seeking Alpha
1 month ago
Avantor, Inc. (AVTR) Q4 2024 Earnings Call Transcript
Avantor, Inc. (NYSE:AVTR ) Q4 2024 Earnings Conference Call February 7, 2025 8:00 AM ET Company Participants Allison Hosak - SVP of Global Communications Michael Stubblefield - President and CEO Brent Jones - EVP and CFO Conference Call Participants Vijay Kumar - Evercore ISI Michael Ryskin - Bank of America Daniel Brennan - TD Cowen Rachel Vatnsdal - JP Morgan Tycho Peterson - Jefferies Luke Sergott - Barclays Patrick Donnelly - Citi Tejas Savant - Morgan Stanley Conor McNamara - RBC Capital Markets Ivy Ma - Goldman Sachs Brandon Couillard - Wells Fargo Jack Meehan - Nephron Research Operator Hello everybody and a warm welcome to Avantor's Fourth Quarter 2024 Earnings Call. My name is Emily and I'll be coordinating your call today.

Positive
Zacks Investment Research
1 month ago
Avantor (AVTR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Avantor (AVTR) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Neutral
Benzinga
1 month ago
Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025
On Friday, Avantor Inc AVTR reported fourth-quarter net sales of $1.69 billion, a decrease of 2% year-over-year, missing the consensus of $1.71 billion.

Charts implemented using Lightweight Charts™